XAGEW Stock Price, Chart, Stats & News
Longevity Health Holdings Inc. (XAGEW) does not currently pay a dividend.
XAGEW chart
Fundamentals
Gross margin | 54.63% |
Operating margin | -400.96% |
Pretax margin | -400.30% |
Net margin | -393.63% |
Effective tax rate | 1.67% |
ROA | -173.88% |
ROE | 141.35% |
D/E | -0.16x |
Interest coverage ratio | -290.33x |
XAGEW valuation
P/E | – |
P/S | 0.31x |
P/B | -0.13x |
P/CF | -0.14x |
P/FCF | -0.12x |
P/OCF | -0.14x |
PEG | 0.00x |
EV multiple | -0.17x |
About
Longevity Health Holdings Inc. is dedicated to advancing plasma-derived bioactive materials (PBMs) designed to stimulate tissue regeneration and recovery following injuries, illnesses, or age-related decline. Their primary product in development, CT-101, functions both as an accelerant for bone healing—with intended uses including the repair of tibia fractures, facilitating foot and ankle fusions, aiding spinal fusions, substituting for dental bone grafts, and filling bone voids—and as a tissue healing accelerator for conditions such as androgenetic alopecia and persistent wounds. This company was established in 2008 and is based in Pittsburgh, Pennsylvania.
Similar securities
Based on sector and market capitalization
